SEC Form 4 · accession 0001209191-16-090771
ACCELERON PHARMA INC · XLRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
CELGENE CORP
10% Owner
Period of report
Jan 11, 2016
Accepted (ET)
Jan 11, 2016 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280600
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 11, 2016 | P | 800,000 | $40.00 | A | 5,372,887 | D |
Table II — derivative securities
No Table II lines on this filing.